A Randomised Trial of Cyclophosphamide With and Without Low Dose Alpha-Interferon in the Treatment of Newly Diagnosed Myeloma
Author:
Publisher
Informa UK Limited
Subject
Cancer Research,Oncology,Hematology
Link
http://www.tandfonline.com/doi/pdf/10.3109/10428199309147377
Reference18 articles.
1. Improved survival times in multiple myeloma treated with melphalan, prednisone, cyclophosphamide, vincristine and BCNU: M-2 protocol
2. Multiple myeloma treated with high dose intravenous melphalan
3. INFUSION OF VINCRISTINE AND DOXORUBICIN WITH ORAL DEXAMETHASONE AS FIRST-LINE THERAPY FOR MULTIPLE MYELOMA
4. INTENSIVE TREATMENT OF MULTIPLE MYELOMA AND CRITERIA FOR COMPLETE REMISSION
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Interferon as therapy for multiple myeloma: an individual patient data overview of 24 randomized trials and 4012 patients;British Journal of Haematology;2001-06
2. Interferon-α treatment in multiple myeloma: Meta-analysis of 30 randomised trials among 3948 patients;Annals of Oncology;2000-11
3. Interferon in Multiple Myeloma - Summary of Treatment Results and Clinical Implications;Acta Oncologica;2000-01
4. Should alpha-interferon be included as standard treatment in multiple myeloma?;European Journal of Cancer;1998-01
5. Should alpha-interferon be included as standard treatment in multiple myeloma?;European Journal of Cancer;1998-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3